Medicare Enrolled
Dr. David Gerst, M.D.
Student in an Organized Health Care Education/Training Program · Rochester, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gerst from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gerst?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gerst
Dr. David Gerst is a student in an organized health care education/training program specialist in Rochester, MI, with 11 years of NPI registration. Based on federal Medicare data, Dr. Gerst performed 3,415 Medicare services across 2,337 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gerst received a total of $1,745 from 26 pharmaceutical and/or device companies across 80 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in student in an organized health care education/training program. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gerst is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years in practice
▲ Top 1% volume in MI
$1,745 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,415
Medicare services
Top 1% in MI for student in an organized health care education/training program
2,337
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~310 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
484 | $97 | $304 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
299 | $8 | $10 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
224 | $10 | $36 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
223 | $8 | $27 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
202 | $13 | $46 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
163 | $145 | $406 |
| Free T3 thyroid hormone test A blood test that measures the level of free triiodothyronine (T3) hormone in your body. This helps assess how well your thyroid gland is functioning. |
156 | $17 | $58 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
155 | $9 | $31 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
152 | $16 | $57 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
140 | $3 | $9 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
134 | $9 | $33 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
126 | $52 | $115 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
120 | $85 | $239 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
115 | $42 | $147 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
108 | $145 | $358 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
85 | $12 | $67 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
72 | $5 | $18 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
65 | $29 | $101 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
57 | $48 | $193 |
| Urine microalbumin test A laboratory test that measures the amount of a specific protein called microalbumin in a urine sample. This analysis helps assess kidney function. |
52 | $6 | $10 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
30 | $29 | $232 |
| PSA test (prostate cancer screening) A blood test that measures the level of prostate-specific antigen to screen for prostate cancer. |
30 | $19 | $63 |
| PSA test (prostate cancer screening) | 27 | $18 | $63 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
26 | $271 | $662 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
25 | $35 | $73 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
22 | $75 | $166 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
22 | $35 | $73 |
| Urine microalbumin test (kidney screening) A laboratory test that measures the amount of microalbumin, a small protein, in a urine sample. This test is used to detect early signs of kidney damage. |
20 | $6 | $20 |
| COVID-19 vaccine administration Administration of a single dose of the coronavirus vaccine. |
17 | $43 | $120 |
| COVID-19 vaccine (Pfizer bivalent) Administration of a 30 mcg dose of the SARS-CoV-2 vaccine via intramuscular injection. |
17 | $121 | $328 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
17 | $239 | $655 |
| SARS-CoV-2 vaccine, 30 mcg/0.3 mL Administration of the SARS-CoV-2 (COVID-19) vaccine containing 30 micrograms of antigen in a 0.3 milliliter dose. |
16 | $46 | $120 |
| Annual depression screening | 14 | $21 | $51 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$1,745
Total received (2021-2024)
Avg $436/year across 4 years
Top 15% in MI for student in an organized health care education/training program
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
80
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,745 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$887
2023
$436
2022
$307
2021
$115
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Bayer Healthcare Pharmaceuticals Inc.
$176
Exact Sciences Corporation
$135
Novo Nordisk Inc
$115
AstraZeneca Pharmaceuticals LP
$97
Lilly USA, LLC
$95
Otsuka America Pharmaceutical, Inc.
$52
Merck Sharp & Dohme LLC
$49
Amgen Inc.
$42
Neurocrine Biosciences, Inc.
$33
Boehringer Ingelheim Pharmaceuticals, Inc.
$23
Xeris Pharmaceuticals, Inc.
$19
Astellas Pharma US Inc
$19
Lundbeck LLC
$17
MEDICOMP INC
$16
Top 3 companies account for 48.1% of 2024 payments
All-time payments by company (2021-2024) ›
Novo Nordisk Inc
$286
Amgen Inc.
$192
Exact Sciences Corporation
$190
Bayer Healthcare Pharmaceuticals Inc.
$176
Lilly USA, LLC
$115
AstraZeneca Pharmaceuticals LP
$97
Vanda Pharmaceuticals Inc.
$68
Bayer HealthCare Pharmaceuticals Inc.
$53
Otsuka America Pharmaceutical, Inc.
$52
Merck Sharp & Dohme LLC
$49
Novartis Pharmaceuticals Corporation
$48
MEDICOMP INC
$48
AbbVie Inc.
$46
Astellas Pharma US Inc
$40
Ethicon US, LLC
$36
GlaxoSmithKline, LLC.
$36
Horizon Therapeutics plc
$35
Neurocrine Biosciences, Inc.
$33
Boehringer Ingelheim Pharmaceuticals, Inc.
$23
PFIZER INC.
$22
Xeris Pharmaceuticals, Inc.
$19
Abbott Laboratories
$18
Lundbeck LLC
$17
JAZZ PHARMACEUTICALS INC.
$16
Almatica Pharma LLC
$16
ABBVIE INC.
$14
Top 3 companies account for 38.3% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · BREZTRI · Cologuard Collection Kit · EVENITY · Enbrel · FARXIGA · FREESTYLE LIBRE 2 · GARDASIL · GRALISE · GVOKE HYPOPEN · HETLIOZ · INGREZZA · JARDIANCE · KRYSTEXXA · Kerendia · LEQVIO · LINX Reflux Management System · MOUNJARO · Myrbetriq · Otezla · Ozempic · PAXLOVID · PENNSAID · QULIPTA · REXULTI · Repatha · Rybelsus · SUNOSI · SYNTHROID · TELEPATCH CARDIAC MONITOR · TRELEGY ELLIPTA · UBRELVY · Veozah · Wegovy
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Student in an organized health care education/training programs within 10 mi
4,445
Per 100K population
349.4
County median income
$95,296
Nearest hospital
ASCENSION PROVIDENCE ROCHESTER HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gerst is a clinical cardiology specialist, with above-average Medicare volume (top 1% in MI), with low-engagement industry engagement in the top 15% of MI peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gerst experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Gerst performed 484 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gerst receive payments from pharmaceutical companies?
Yes. Dr. Gerst received a total of $1,745 from 26 companies across 80 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gerst's costs compare to other student in an organized health care education/training programs in Rochester?
Dr. Gerst's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gerst) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Student In An Organized Health Care Education/training Programs in Rochester
Browse student in an organized health care education/training programs in Rochester ranked by procedure volume and transparency data.
Highest volume
Top Student In An Organized Health Care Education/training Programs in MI
Student in an organized health care education/training programs ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Student In An Organized Health Care Education/training Programs in MI
Which MI student in an organized health care education/training programs receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Exact Sciences Corporation Payments to Doctors
See all physicians who received payments from Exact Sciences Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology